Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | March 29, 2018 | April 02, 2018 |
| WELLS FARGO & COMPANY/MNWFC · Entity 2824 | Director | April 01, 2013 | April 02, 2013 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GILEAD SCIENCES, INC.
Report date March 29, 2018 · Filed April 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 27,375.7941 |
Reported balance
After 2018-03-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-03-29 · Grant · Acquired 205.4266 · Balance 27,375.7941 F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.
F2: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.
F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.
WELLS FARGO & COMPANY/MN
Report date April 01, 2013 · Filed April 02, 2013
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 61,962.9483 |
Reported balance
After 2013-04-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2013-04-01 · Grant · Acquired 1,651.7736 · Balance 61,962.9483 F2: Conversion price is 1-for-1 F3: Deferred compensation shares payable in installments depending upon director's election. |
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | Direct | 1,122.938 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,122.938 F1: Includes 7.866 shares acquired through Wells Fargo & Company's dividend reinvestment plan on 3/1/2013. |
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | IndirectThrough Family Trust | 1,000 |
Reported balance
Holding disclosure · report date 2013-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 7.866 shares acquired through Wells Fargo & Company's dividend reinvestment plan on 3/1/2013.
F2: Conversion price is 1-for-1
F3: Deferred compensation shares payable in installments depending upon director's election.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2008 Filed Feb 28, 2008 19:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 36,000 | $15.70 | $565,200.00 |
DisclosureSEC source: 0001179110-08-004477 · edgar.xml · nonDerivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:27 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 700 | $43.97 | $30,779.00 |
DisclosureSEC source: 0001179110-08-004478 · edgar.xml · nonDerivative · entry 2 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 26, 2008 Filed Feb 28, 2008 19:27 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 5,200 | $43.95 | $228,540.00 |
DisclosureSEC source: 0001179110-08-004478 · edgar.xml · nonDerivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Read SEC document |
| January 01, 2008 Filed Jan 2, 2008 22:44 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 819.8079 | $30.19 | $24,750.00 |
DisclosureSEC source: 0001193833-08-000006 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,635.9101 Underlying: Common Stock, $1 2/3 par value · 819.8079 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership. F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership. Read SEC document |
| October 01, 2007 Filed Oct 2, 2007 22:26 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 750.9826 | $35.62 | $26,750.00 |
DisclosureSEC source: 0001193833-07-000166 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,732.6266 Underlying: Common Stock, $1 2/3 par value · 750.9826 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership. F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership. Read SEC document |
| July 01, 2007 Filed Jul 5, 2007 17:05 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 874.3247 | $35.17 | $30,750.00 |
DisclosureSEC source: 0001193833-07-000132 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,914.4985 Underlying: Common Stock, $1 2/3 par value · 874.3247 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership. F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership. Read SEC document |
| June 28, 2007 Filed Jul 2, 2007 19:26 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Shares · Derivative | 884.06 | $0.00 Strike: $39.59 | $0.00 |
DisclosureSEC source: 0001179110-07-014126 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 884.06 Underlying: Common Stock · 884.06 shares Expires not disclosed F1 · derivative.exercise_price: All shares and dollar amounts reflect a two-for-one split that was effected on June 22, 2007 benefiting all shareholders of record as of May 24, 2007. F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| May 09, 2007 Filed May 11, 2007 23:07 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 32,500 | $0.00 Strike: $82.82 | $0.00 |
DisclosureSEC source: 0001179110-07-009845 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2017-05-09 F1 · derivative.exercise_date: Options vested in full on May 9, 2007, the date of grant. Read SEC document |
| April 24, 2007 Filed Apr 25, 2007 23:16 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantDirector Stock Purchase Option · Derivative | 7,394 | $0.00 Strike: $35.78 | $0.00 |
DisclosureSEC source: 0001193833-07-000096 · edgar.xml · derivative · entry 2 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,394 Underlying: Common Stock, $1 2/3 par value · 7,394 shares Expires 2017-04-24 Read SEC document |
| April 24, 2007 Filed Apr 25, 2007 23:16 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 1,957 | $35.78 | $70,021.46 |
DisclosureSEC source: 0001193833-07-000096 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,985.974 Underlying: Common Stock, $1 2/3 par value · 1,957 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership. F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership. Read SEC document |
| April 01, 2007 Filed Apr 2, 2007 18:35 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 951.2053 | $34.43 | $32,750.00 |
DisclosureSEC source: 0001193833-07-000063 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,028.974 Underlying: Common Stock, $1 2/3 par value · 951.2053 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership. F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership. Read SEC document |
| January 01, 2007 Filed Jan 3, 2007 18:51 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 681.946 | $35.56 | $24,250.00 |
DisclosureSEC source: 0001193833-07-000009 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,018.6161 Underlying: Common Stock, $1 2/3 par value · 681.946 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1 F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership F3 · balance_after: Amount reflects a 2-for-1 stock split in the form of a 100 percent stock dividend distributed on August 11, 2006 Read SEC document |
| January 01, 2007 Filed Apr 4, 2007 22:49 UTC Amendment | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 681.946 | $35.56 | $24,250.00 |
DisclosureSEC source: 0001193833-07-000079 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,045.1278 Underlying: Common Stock, $1 2/3 par value · 681.946 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership. F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership. Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified stock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $26.73 | $0.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · derivative · entry 31 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2014-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vested in two equal annual installments beginning on March 23, 2005, the first anniversary date of the grant. Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 265 | $68.29 | $18,096.85 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 30 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,735 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $68.30 | $6,830.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 29 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $68.48 | $6,848.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 28 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,100 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 200 | $68.53 | $13,706.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 27 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 621 | $68.54 | $42,563.34 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 26 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 721 | $68.55 | $49,424.55 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 25 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,021 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $68.56 | $6,856.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 24 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,742 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 179 | $68.57 | $12,274.03 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 23 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,842 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $68.59 | $6,859.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 22 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,021 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 590 | $68.60 | $40,474.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 21 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,121 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,700 | $68.61 | $116,637.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 20 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,711 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,000 | $68.62 | $68,620.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 19 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,411 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 600 | $68.63 | $41,178.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 18 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,411 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,031 | $68.64 | $70,767.84 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 17 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,011 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,500 | $68.65 | $102,975.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 16 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,042 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $68.66 | $6,866.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 15 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,542 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,166 | $68.68 | $80,080.88 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 14 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,642 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,971 | $68.69 | $135,387.99 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 13 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,808 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 2,495 | $68.70 | $171,406.50 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 12 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,779 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,332 | $68.71 | $91,521.72 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 11 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,274 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 3,466 | $68.72 | $238,183.52 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 10 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,606 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 962 | $68.73 | $66,118.26 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 9 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,072 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 2,886 | $68.74 | $198,383.64 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 8 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,034 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,882 | $68.75 | $129,387.50 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 7 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 841 | $68.76 | $57,827.16 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 6 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,782 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,197 | $68.77 | $82,317.69 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 5 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,623 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 280 | $68.78 | $19,258.40 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 4 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,820 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 700 | $68.79 | $48,153.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 3 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,100 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 200 | $68.80 | $13,760.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 2 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,800 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:43 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 30,000 | $26.73 | $801,900.00 |
DisclosureSEC source: 0001179110-06-022223 · edgar.xml · nonDerivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 134 | $68.18 | $9,136.12 |
DisclosureSEC source: 0001179110-06-022224 · edgar.xml · nonDerivative · entry 5 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $68.19 | $6,819.00 |
DisclosureSEC source: 0001179110-06-022224 · edgar.xml · nonDerivative · entry 4 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 366 | $68.20 | $24,961.20 |
DisclosureSEC source: 0001179110-06-022224 · edgar.xml · nonDerivative · entry 3 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 300 | $68.22 | $20,466.00 |
DisclosureSEC source: 0001179110-06-022224 · edgar.xml · nonDerivative · entry 2 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Read SEC document |
| November 17, 2006 Filed Nov 22, 2006 00:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 835 | $68.27 | $57,005.45 |
DisclosureSEC source: 0001179110-06-022224 · edgar.xml · nonDerivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 Read SEC document |
| October 01, 2006 Filed Oct 3, 2006 00:35 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 626.0365 | $36.18 | $22,650.00 |
DisclosureSEC source: 0001193833-06-000149 · edgar.xml · derivative · entry 1 MOORE NICHOLAS G · CIK 0001216923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,336.6701 Underlying: Common Stock, $1 2/3 par value · 626.0365 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1 F2 · derivative.exercise_date: Payable in 10 installments beginning July 1 following cessation of board membership F2 · derivative.expiration_date: Payable in 10 installments beginning July 1 following cessation of board membership F3 · balance_after: Amount reflects a 2-for-1 stock split in the form of a 100 percent stock dividend distributed on August 11, 2006 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.